Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$70.4K Buy
200
+15
+8% +$5.35K 0.04% 122
2025
Q4
$60.6K Buy
185
+140
+311% +$44.4K 0.04% 134
2025
Q3
$12.7K Hold
45
0.01% 192
2025
Q2
$12.6K Hold
45
0.01% 190
2025
Q1
$14K Hold
45
0.01% 179
2024
Q4
$11.7K Hold
45
0.01% 181
2024
Q3
$14.5K Hold
45
0.01% 176
2024
Q2
$14.1K Hold
45
0.01% 183
2024
Q1
$12.8K Sell
45
-20
-31% -$5.85K 0.01% 188
2023
Q4
$18.7K Hold
65
0.01% 179
2023
Q3
$17.5K Buy
65
+20
+44% +$4.99K 0.01% 172
2023
Q2
$10K Hold
45
0.01% 173
2023
Q1
$11K Sell
45
-25
-36% -$6.14K 0.01% 172
2022
Q4
$18K Hold
70
0.01% 173
2022
Q3
$16K Hold
70
0.01% 169
2022
Q2
$17K Sell
70
-25
-26% -$6.13K 0.01% 174
2022
Q1
$23K Buy
+95
New +$21.8K 0.01% 173
2021
Q2
Sell
-225
Closed -$56K 183
2021
Q1
$56K Sell
225
-50
-18% -$11.9K 0.04% 139
2020
Q4
$63K Buy
+275
New +$63.4K 0.04% 130

Other funds holding AMGN

Tacita Capital's AMGN Position: Q1 2026 in Review

Tacita Capital increased its Amgen (AMGN) stake by 8.1% in Q1 2026, buying an estimated $5.35K and bringing the position to 200 shares worth $70.4K. The position accounts for 0.04% of the portfolio, ranked #122.

Tacita Capital first reported a position in AMGN in Q4 2020 and has held it in 19 quarters since. 3,127 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Tacita Capital held 200 shares of Amgen worth $70.4K as of Q1 2026.
  • Tacita Capital bought 15 Amgen shares in Q1 2026, an estimated $5.35K.
  • Amgen made up 0.04% of Tacita Capital's portfolio in Q1 2026, its #122 holding.
  • Tacita Capital first reported a position in Amgen in Q4 2020 and has held it in 19 quarters since.
  • 3,127 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Tacita Capital's 13F filing for Q1 2026, filed 7 May 2026.